TKM-100802 for Injection
TKM-EBOV-002
Phase 1 small_molecule terminated
Quick answer
TKM-100802 for Injection for Ebola Virus Infection is a Phase 1 program (small_molecule) at Arbutus Biopharma Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arbutus Biopharma Corp
- Indication
- Ebola Virus Infection
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated